You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: October 3, 2023


✉ Email this page to a colleague

« Back to Dashboard

When do Cefazolin And Dextrose patents expire, and what generic alternatives are available?

Cefazolin And Dextrose is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFAZOLIN AND DEXTROSE is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin And Dextrose

A generic version of CEFAZOLIN AND DEXTROSE was approved as cefazolin sodium by SANDOZ on December 9th, 1988.

  Try a Trial

Drug patent expirations by year for CEFAZOLIN AND DEXTROSE
Recent Clinical Trials for CEFAZOLIN AND DEXTROSE

Identify potential brand extensions & 505(b)(2) entrants

Abdul El-RabbanyPhase 4
Assistance Publique Hopitaux De MarseillePhase 4
Leiden University Medical CenterPhase 4

See all CEFAZOLIN AND DEXTROSE clinical trials


US Patents and Regulatory Information for CEFAZOLIN AND DEXTROSE

CEFAZOLIN AND DEXTROSE is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting CEFAZOLIN AND DEXTROSE

Exclusivity Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFAZOLIN AND DEXTROSE cefazolin sodium INJECTABLE;INJECTION 050779-002 Jul 27, 2000 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
B Braun CEFAZOLIN AND DEXTROSE cefazolin sodium INJECTABLE;INJECTION 050779-003 Jan 13, 2012 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
B Braun CEFAZOLIN AND DEXTROSE cefazolin sodium INJECTABLE;INJECTION 050779-001 Jul 27, 2000 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.